Profile: Ab Science SA (ABS.PA)
ABS.PA on Paris Stock Exchange
Price Change (% chg)
AB Science SA is a France-based pharmaceutical company specialized in the research, discovery, development and marketing of protein kinase inhibitors (PKIs). It is cpecialized in tageted therapies through tyrosine kinase inhibitors for treating diseases with high medical in the field of cancers, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine. Masitinib is a tyrosine kinase inhibitor used as a veterinary medicine in the treatment of canine mast cell tumors. The Company is present in the United States and Europe. As of December 31, 2011, the Company operated though a subsidiary, AB Science USA LCC, based in the United States.
Ab Science SA
3, Avenue George V